Bone Therapeutics SA of Belgium has raised €7.7 million from existing private and institutional investors and the Walloon regional government to advance the clinical development of its lead cell therapy product for bone disease. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News
